| Page 2070 | Kisaco Research
Showcase Presenter Profiles - UK 2018
 

Dr. Uwe Marx

CEO
TissUse

Trained in human biology and medicine, Dr. Marx is an accomplished entrepreneur and the scientific founder of TissUse, a spin-off of the Institute of Biotechnology of the Technische Universität Berlin, Germany. Over the course of his fruitful career in biotechnology, Dr. Marx has pursued ever more lifelike structures that can mimic human biology in vitro. Prior to founding TissUse, Dr. Marx was head of the “Multi-Organ-Chip” program at the University and the scientific co-founder at two successful Germany-based biotechs, ProBioGen AG and VITA 34.

Read full bio

Dr. Uwe Marx

CEO
TissUse

Dr. Uwe Marx

CEO
TissUse

Trained in human biology and medicine, Dr. Marx is an accomplished entrepreneur and the scientific founder of TissUse, a spin-off of the Institute of Biotechnology of the Technische Universität Berlin, Germany. Over the course of his fruitful career in biotechnology, Dr. Marx has pursued ever more lifelike structures that can mimic human biology in vitro. Prior to founding TissUse, Dr. Marx was head of the “Multi-Organ-Chip” program at the University and the scientific co-founder at two successful Germany-based biotechs, ProBioGen AG and VITA 34.

 
Oncobiome Congress
8-9 May 2018
Boston, USA
The influence of the microbiome on human health & disease has been a growing area of interest in recent years, however until recently the impact of the microbiome on the initiation, progression & treatment of cancer was unknown. In recent months research has uncovered the potential of the microbiome to improve cancer therapies and to be a useful tool for patient stratification and diagnostics. With a better understanding of the oncobiome there is the potential to improve patient outcomes and increase the efficacy of existing therapies and drugs.
Visit Site